Section Arrow
AMIX.NASDAQ
- Autonomix Medical Inc.
Quotes are at least 15-min delayed:2026/11/20 17:24 EST
After Hours
Last
 0.9017
+0.0106 (+1.19%)
Bid
0.86
Ask
0.9
High 0.9144 
Low 0.8675 
Volume 836 
Regular Hours (Closed)
Last
 0.8911
-0.1489 (-14.32%)
Day High 
1.04 
Prev. Close
1.04 
1-M High
3.3 
Volume 
196.80K 
Bid
0.86
Ask
0.9
Day Low
0.8787 
Open
1.04 
1-M Low
0.932 
Market Cap 
2.13M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.36 
20-SMA 1.63 
50-SMA 2.79 
52-W High 24.68 
52-W Low 0.932 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.89/--
Enterprise Value
3.13M
Balance Sheet
Book Value Per Share
3.39
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 41.9407 -0.0393 -0.09%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.61 -0.02 -1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.5 -0.44 -0.44%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.9699 +0.0609 +6.70%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 104.43 +1.43 +1.39%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.